[{"Assets_0_Q1_USD":4499800000.0,"CommonStockSharesConverted_0_Q1_shares":145221009.0,"CommonStockSharesOutstanding_0_Q1_shares":145221009.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":41200000.0,"NetIncomeLossConverted_1_Q1_USD":-14400000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":142149315.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":142149315.0,"StockholdersEquity_0_Q1_USD":1529400000.0,"StockholdersEquityConverted_0_Q1_USD":1529400000.0,"EarningsPerShareBasic_1_Q1_USD":-0.1,"EarningsPerShareDiluted_1_Q1_USD":-0.1,"RevenuesConverted_1_Q1_USD":551800000.0,"Ticker":"CTLT","CIK":"1596783","name":"CATALENT, INC.","OfficialName":"Catalent Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"17076283108.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20181106"}]